Recombinant Growth Factor for Periodontal Applications
Last Updated: Jan 06, 2006
![]Gems](http://osseonews.blogs.com/.shared/image.html?/photos/uncategorized/gems.gif)GEM 21S® (Growth-factor Enhanced Matrix) has been approved by the U.S. Food and Drug Administration (FDA). GEM
21S® is a fully synthetic regeneration system for the treatment of
periodontal bone defects and associated gingival recession.
GEM 21S® is composed of the tissue growth factor, recombinant human
Platelet-Derived Growth Factor (rhPDGF-BB), and a synthetic bone
matrix, Beta-tricalcium phosphate (ß-TCP). It is the first
totally synthetic product combining a purified recombinant growth
factor with a synthetic bone matrix to be approved by the FDA for human
application. In
recognition of the unique treatment modality provided by GEM 21S®, the
FDA has established it as a first-in-class product in its treatment
category.
Read the entire press release by clicking here. Please feel free to leave your comments below.
3 Comments on Recombinant Growth Factor for Periodontal Applications
Anon
01/30/2006
Anon
02/01/2006
Featured Products
Classic 50/50 Mix
Promotes osteoconduction
Provides structural integrity
Convenient Syringe!
50/50 Cortical/Cancellous
Available in 3 sizes.
Eliminate hassle of mixing particulate grafts
Sold in packs of 5 or packs of 10.
Proven safe, and clinically effective
Resorbable collagen membrane derived from purified porcine pericardium
Fast hydration and excellent tensile strength
Good adaptation to various defects
Excellent tear function and duration
100% allograft
Eliminates mixing hassle
Moldable after hydration

Anon
01/23/2006